Cardiovascular Sciences Stock Net Income
| CVSCDelisted Stock | USD 0.0001 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Cardiovascular Sciences' long-term financial health and intrinsic value.
Cardiovascular |
Cardiovascular Sciences Company Net Income Analysis
Cardiovascular Sciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Cardiovascular Sciences Net Income | 169.56 K |
Most of Cardiovascular Sciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Cardiovascular Sciences reported net income of 169.56 K. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is notably lower than that of the firm.
Cardiovascular Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiovascular Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiovascular Sciences could also be used in its relative valuation, which is a method of valuing Cardiovascular Sciences by comparing valuation metrics of similar companies.Cardiovascular Sciences is currently under evaluation in net income category among its peers.
Cardiovascular Fundamentals
| Profit Margin | 0.85 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | (4.76 K) | |||
| Shares Outstanding | 16.96 M | |||
| Price To Sales | 0.01 X | |||
| Revenue | 321.66 K | |||
| Gross Profit | 321.66 K | |||
| Net Income | 169.56 K | |||
| Cash And Equivalents | 6.46 K | |||
| Total Debt | 119.21 K | |||
| Current Ratio | 0.68 X | |||
| Book Value Per Share | 0.09 X | |||
| Earnings Per Share | 0.01 X | |||
| Beta | -93.05 | |||
| Market Capitalization | 1.6 K | |||
| Total Asset | 1.56 M | |||
| Working Capital | (487 K) | |||
| Current Asset | 12 K | |||
| Current Liabilities | 499 K | |||
| Net Asset | 1.56 M |
About Cardiovascular Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardiovascular Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Sciences' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |